article thumbnail

Consumers Are Replacing Pharmaceuticals With Medical Marijuana

The Fresh Toast

Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses.

article thumbnail

The Pharmaceutical Industry’s Relationship With Cannabis

Kind Meds (Cannabis Education Blog)

Cannabis has had a long, changing history in the United States. Now, as the future of cannabis seems to be promising across the country, there are still many obstacles in the way of medical cannabis becoming legal. At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the U.S. territories.

article thumbnail

Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs?

United Patients Group

Introduction The medical marijuana industry has been growing rapidly in the United States, and for good reason. Cannabis is a natural treatment for pain and other symptoms of withdrawal, and has been shown to help manage the side effects of drugs and even has be used as a substitute for prescription medications.

article thumbnail

47% of Canadian Marijuana Patients Substitute Cannabis for Other Substances

CannaMD

As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.

Patients 135
article thumbnail

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive

SpeedWeed

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive – Cannabis and Marijuana industry news. The post Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 View original article.

article thumbnail

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility

Cannabis Law Report

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East. The move follows seven harvests and extractions in 2022 and the […]